Check out my podcast, Life Sciences Rush Hour - Investing, News, Risk Management and any other topic impacting the space, on Apple Podcasts! https://itunes.apple.com/us/podcast/life-sciences-rush-hour-investing-news-risk-management/id1384888594?mt=2&uo=4
Category: Uncategorized
Why Benchmarking Should Not Be Used When Deciding on Directors & Officers Limit
The other day I discussed the rising number of Securities Class Action Filings (here) against publicly traded companies and how they are almost inevitable with just under 9% of all publicly traded companies expected to face a filing in 2018. D&O insurance will or should respond to these filings which transfers much of the financial … Continue reading Why Benchmarking Should Not Be Used When Deciding on Directors & Officers Limit
Top 10 Pharma Companies +1 (Infographic)
With the Takeda/Shire merger all set here is how the top 10 Pharma companies based on sales now shakeout, plus Gilead at number 11. Via EndPoints News (The (new) top 10 pharma companies by 2017 revenue)